The DOI matches its Crossref record; 88 of the 88 references it cites were found in a registry or an index.
Allosteric sodium in class A GPCR signaling
Open accessAbstract
Despite their functional and structural diversity, G protein-coupled receptors (GPCRs) share a common mechanism of signal transduction via conformational changes in the seven-transmembrane (7TM) helical domain. New major insights into this mechanism come from the recent crystallographic discoveries of a partially hydrated sodium ion that is specifically bound in the middle of the 7TM bundle of multiple class A GPCRs. This review discusses the remarkable structural conservation and distinct features of the Na+ pocket in this most populous GPCR class, as well as the conformational collapse of the pocket on receptor activation. New insights help to explain allosteric effects of sodium on GPCR agonist binding and activation, and sodium’s role as a potential co-factor in class A GPCR function.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lodish, H. F. (1986) · Cited by 5,650
Crystal Structure of Rhodopsin: A G Protein-Coupled Receptor
Palczewski, K., Kumasaka, T., Hori, T., Behnke, C. A., Motoshima, H., Fox, B. A., Trong, I. L., Teller, D. C., Okada, T., Stenkamp, R. E., et al. (2000) · Science · doi:10.1126/science.289.5480.739 · Cited by 5,637
High-Resolution Crystal Structure of an Engineered Human β 2 -Adrenergic G Protein–Coupled Receptor
Cherezov, V., Rosenbaum, D. M., Hanson, M. A., Rasmussen, S. G. F., Thian, F. S., Kobilka, T. S., Choi, H.-J., Kuhn, P., Weis, W. I., Kobilka, B. K., et al. (2007) · Science · doi:10.1126/science.1150577 · Cited by 3,264
Self-citationCrystal structure of the β2 adrenergic receptor–Gs protein complex
Rasmussen, S. G. F., DeVree, B. T., Zou, Y., Kruse, A. C., Chung, K. Y., Kobilka, T. S., Thian, F. S., Chae, P. S., Pardon, E., Calinski, D., et al. (2011) · Nature · doi:10.1038/nature10361 · Cited by 3,009
Ballesteros, J. A., & Weinstein, H. (1995) · Methods in Neurosciences · doi:10.1016/s1043-9471(05)80049-7 · Cited by 2,999
Fredriksson, R., Lagerström, M. C., Lundin, L.-G., & Schiöth, H. B. (2003) · Molecular Pharmacology · doi:10.1124/mol.63.6.1256 · Cited by 2,941
The 2.6 Angstrom Crystal Structure of a Human A 2A Adenosine Receptor Bound to an Antagonist
Jaakola, V.-P., Griffith, M. T., Hanson, M. A., Cherezov, V., Chien, E. Y. T., Lane, J. R., IJzerman, A. P., & Stevens, R. C. (2008) · Science · doi:10.1126/science.1164772 · Cited by 1,781
Self-citationTransduction of Receptor Signals by ß-Arrestins
Lefkowitz, R. J., & Shenoy, S. K. (2005) · Science · doi:10.1126/science.1109237 · Cited by 1,727
Structural diversity of G protein-coupled receptors and significance for drug discovery
Lagerström, M. C., & Schiöth, H. B. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2518 · Cited by 1,492
Crystal structure of the µ-opioid receptor bound to a morphinan antagonist
Manglik, A., Kruse, A. C., Kobilka, T. S., Thian, F. S., Mathiesen, J. M., Sunahara, R. K., Pardo, L., Weis, W. I., Kobilka, B. K., & Granier, S. (2012) · Nature · doi:10.1038/nature10954 · Cited by 1,356
Lgr5 homologues associate with Wnt receptors and mediate R-spondin signalling
de Lau, W., Barker, N., Low, T. Y., Koo, B.-K., Li, V. S. W., Teunissen, H., Kujala, P., Haegebarth, A., Peters, P. J., van de Wetering, M., et al. (2011) · Nature · doi:10.1038/nature10337 · Cited by 1,272
Functional Selectivity and Classical Concepts of Quantitative Pharmacology
Urban, J. D., Clarke, W. P., von Zastrow, M., Nichols, D. E., Kobilka, B., Weinstein, H., Javitch, J. A., Roth, B. L., Christopoulos, A., Sexton, P. M., et al. (2007) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.104463 · Cited by 1,116
Self-citationStructure-Function of the G Protein–Coupled Receptor Superfamily
Katritch, V., Cherezov, V., & Stevens, R. C. (2013) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-032112-135923 · Cited by 1,054
Self-citationStructural Basis for Allosteric Regulation of GPCRs by Sodium Ions
Liu, W., Chun, E., Thompson, A. A., Chubukov, P., Xu, F., Katritch, V., Han, G. W., Roth, C. B., Heitman, L. H., IJzerman, A. P., et al. (2012) · Science · doi:10.1126/science.1219218 · Cited by 945
Self-citationStructure of the human κ-opioid receptor in complex with JDTic
Wu, H., Wacker, D., Mileni, M., Katritch, V., Han, G. W., Vardy, E., Liu, W., Thompson, A. A., Huang, X.-P., Carroll, F. I., et al. (2012) · Nature · doi:10.1038/nature10939 · Cited by 879
Self-citationAgonist-bound adenosine A2A receptor structures reveal common features of GPCR activation
Lebon, G., Warne, T., Edwards, P. C., Bennett, K., Langmead, C. J., Leslie, A. G. W., & Tate, C. G. (2011) · Nature · doi:10.1038/nature10136 · Cited by 873
Conformational biosensors reveal GPCR signalling from endosomes
Irannejad, R., Tomshine, J. C., Tomshine, J. R., Chevalier, M., Mahoney, J. P., Steyaert, J., Rasmussen, S. G. F., Sunahara, R. K., El-Samad, H., Huang, B., et al. (2013) · Nature · doi:10.1038/nature12000 · Cited by 819 · cited 1×
“, in neuron synapses or endosomes that carry internalized GPCRs [68,70]) affect the spatio-temporal profile of GPCR signaling? Katritch et al.”
BackgroundStructure of an Agonist-Bound Human A 2A Adenosine Receptor
Xu, F., Wu, H., Katritch, V., Han, G. W., Jacobson, K. A., Gao, Z.-G., Cherezov, V., & Stevens, R. C. (2011) · Science · doi:10.1126/science.1202793 · Cited by 813
Self-citationStructure and dynamics of the M3 muscarinic acetylcholine receptor
Kruse, A. C., Hu, J., Pan, A. C., Arlow, D. H., Rosenbaum, D. M., Rosemond, E., Green, H. F., Liu, T., Chae, P. S., Dror, R. O., et al. (2012) · Nature · doi:10.1038/nature10867 · Cited by 811
Structure of the human M2 muscarinic acetylcholine receptor bound to an antagonist
Haga, K., Kruse, A. C., Asada, H., Yurugi-Kobayashi, T., Shiroishi, M., Zhang, C., Weis, W. I., Okada, T., Kobilka, B. K., Haga, T., et al. (2012) · Nature · doi:10.1038/nature10753 · Cited by 792
Signalling bias in new drug discovery: detection, quantification and therapeutic impact
Kenakin, T., & Christopoulos, A. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd3954 · Cited by 740
Biased Signaling Pathways in β 2 -Adrenergic Receptor Characterized by 19 F-NMR
Liu, J. J., Horst, R., Katritch, V., Stevens, R. C., & Wüthrich, K. (2012) · Science · doi:10.1126/science.1215802 · Cited by 697
Self-citationStructural Features for Functional Selectivity at Serotonin Receptors
Wacker, D., Wang, C., Katritch, V., Han, G. W., Huang, X.-P., Vardy, E., McCorvy, J. D., Jiang, Y., Chu, M., Siu, F. Y., et al. (2013) · Science · doi:10.1126/science.1232808 · Cited by 664
Self-citation(1987) · General Pharmacology: The Vascular System · doi:10.1016/0306-3623(87)90055-3 · Cited by 640
Seifert, R., & Wenzel-Seifert, K. (2002) · Naunyn-Schmiedeberg's Archives of Pharmacology · doi:10.1007/s00210-002-0588-0 · Cited by 637
Activation mechanism of the β2-adrenergic receptor
Dror, R. O., Arlow, D. H., Maragakis, P., Mildorf, T. J., Pan, A. C., Xu, H., Borhani, D. W., & Shaw, D. E. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1110499108 · Cited by 623
Molecular Mechanism of β-Arrestin-Biased Agonism at Seven-Transmembrane Receptors
Reiter, E., Ahn, S., Shukla, A. K., & Lefkowitz, R. J. (2012) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.010909.105800 · Cited by 583
Opiate Agonists and Antagonists Discriminated by Receptor Binding in Brain
Pert, C. B., Pasternak, G., & Snyder, S. H. (1973) · Science · doi:10.1126/science.182.4119.1359 · Cited by 546
Structure of the agonist-bound neurotensin receptor
White, J. F., Noinaj, N., Shibata, Y., Love, J., Kloss, B., Xu, F., Gvozdenovic-Jeremic, J., Shah, P., Shiloach, J., Tate, C. G., et al. (2012) · Nature · doi:10.1038/nature11558 · Cited by 509
Molecular control of δ-opioid receptor signalling
Fenalti, G., Giguere, P. M., Katritch, V., Huang, X.-P., Thompson, A. A., Cherezov, V., Roth, B. L., & Stevens, R. C. (2014) · Nature · doi:10.1038/nature12944 · Cited by 497
Self-citationStructure of the nociceptin/orphanin FQ receptor in complex with a peptide mimetic
Thompson, A. A., Liu, W., Chun, E., Katritch, V., Wu, H., Vardy, E., Huang, X.-P., Trapella, C., Guerrini, R., Calo, G., et al. (2012) · Nature · doi:10.1038/nature11085 · Cited by 477
Self-citationDiversity and modularity of G protein-coupled receptor structures
Katritch, V., Cherezov, V., & Stevens, R. C. (2012) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2011.09.003 · Cited by 456
Self-citationHigh-resolution crystal structure of human protease-activated receptor 1
Zhang, C., Srinivasan, Y., Arlow, D. H., Fung, J. J., Palmer, D., Zheng, Y., Green, H. F., Pandey, A., Dror, R. O., Shaw, D. E., et al. (2012) · Nature · doi:10.1038/nature11701 · Cited by 455
Activation of rhodopsin: new insights from structural and biochemical studies
Okada, T., Ernst, O. P., Palczewski, K., & Hofmann, K. P. (2001) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(01)01799-6 · Cited by 413 · cited 1×
“Such photochemical isomerization provides abundant energy for the receptor activation (ΔG ~ 35 kcal/mol [27]), which is several fold higher than the energy contributed by small diffusible ligands.”
BackgroundStructure of the human P2Y12 receptor in complex with an antithrombotic drug
Zhang, K., Zhang, J., Gao, Z.-G., Zhang, D., Zhu, L., Han, G. W., Moss, S. M., Paoletta, S., Kiselev, E., Lu, W., et al. (2014) · Nature · doi:10.1038/nature13083 · Cited by 397
Self-citationPersistent signaling induced by FTY720-phosphate is mediated by internalized S1P1 receptors
Mullershausen, F., Zecri, F., Cetin, C., Billich, A., Guerini, D., & Seuwen, K. (2009) · Nature Chemical Biology · doi:10.1038/nchembio.173 · Cited by 370
Ligand binding and micro-switches in 7TM receptor structures
Nygaard, R., Frimurer, T. M., Holst, B., Rosenkilde, M. M., & Schwartz, T. W. (2009) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2009.02.006 · Cited by 346
Rask-Andersen, M., Masuram, S., & Schiöth, H. B. (2014) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-011613-135943 · Cited by 282
Horstman, D. A., Brandon, S., Wilson, A. L., Guyer, C. A., Cragoe, E. J., & Limbird, L. E. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)45781-x · Cited by 271
Signaling by internalized G-protein-coupled receptors
Calebiro, D., Nikolaev, V. O., Persani, L., & Lohse, M. J. (2010) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2010.02.002 · Cited by 266
Restructuring G-Protein- Coupled Receptor Activation
Audet, M., & Bouvier, M. (2012) · Cell · doi:10.1016/j.cell.2012.09.003 · Cited by 262
The effect of ligand efficacy on the formation and stability of a GPCR-G protein complex
Yao, X. J., Vélez Ruiz, G., Whorton, M. R., Rasmussen, S. G. F., DeVree, B. T., Deupi, X., Sunahara, R. K., & Kobilka, B. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0811437106 · Cited by 246
Angel, T. E., Chance, M. R., & Palczewski, K. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0903545106 · Cited by 235
Sealfon, S. C., Chi, L., Ebersole, B. J., Rodic, V., Zhang, D., Ballesteros, J. A., & Weinstein, H. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.28.16683 · Cited by 221
Historical review: Opioid receptors
Snyder, S. H., & Pasternak, G. W. (2003) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(03)00066-x · Cited by 221
Warne, T., Edwards, P. C., Leslie, A. G. W., & Tate, C. G. (2012) · Structure · doi:10.1016/j.str.2012.03.014 · Cited by 220
Strategies to Discover Unexpected Targets for Drugs Active at G Protein–Coupled Receptors
Allen, J. A., & Roth, B. L. (2011) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010510-100553 · Cited by 216
Self-citationKrishnan, A., Almén, M. S., Fredriksson, R., & Schiöth, H. B. (2012) · PLoS ONE · doi:10.1371/journal.pone.0029817 · Cited by 204 · cited 1×
“• Could the Na+ site confer a key evolutionary advantage to class A GPCRs, the youngest but most sprawling of all human GPCR classes [88]?”
BackgroundNeve, K. A., Cox, B. A., Henningsen, R. A., Spanoyannis, A., & Neve, R. L. (1991) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)11081-x · Cited by 189
Moukhametzianov, R., Warne, T., Edwards, P. C., Serrano-Vega, M. J., Leslie, A. G. W., Tate, C. G., & Schertler, G. F. X. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1100185108 · Cited by 176
Miller-Gallacher, J. L., Nehmé, R., Warne, T., Edwards, P. C., Schertler, G. F. X., Leslie, A. G. W., & Tate, C. G. (2014) · PLoS ONE · doi:10.1371/journal.pone.0092727 · Cited by 172
Bihoreau, C., Monnot, C., Davies, E., Teutsch, B., Bernstein, K. E., Corvol, P., & Clauser, E. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.11.5133 · Cited by 166
Movement of ‘gating charge’ is coupled to ligand binding in a G-protein-coupled receptor
Ben-Chaim, Y., Chanda, B., Dascal, N., Bezanilla, F., Parnas, I., & Parnas, H. (2006) · Nature · doi:10.1038/nature05259 · Cited by 164
Christopher, J. A., Brown, J., Doré, A. S., Errey, J. C., Koglin, M., Marshall, F. H., Myszka, D. G., Rich, R. L., Tate, C. G., Tehan, B., et al. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm400140q · Cited by 163
Barak, L. S., Ménard, L., Ferguson, S. S. G., Colapietro, A.-M., & Caron, M. G. (1995) · Biochemistry · doi:10.1021/bi00047a003 · Cited by 156
Factors Governing Metal−Ligand Distances and Coordination Geometries of Metal Complexes
Kuppuraj, G., Dudev, M., & Lim, C. (2009) · The Journal of Physical Chemistry B · doi:10.1021/jp807972e · Cited by 149
Gutiérrez‐de‐Terán, H., Massink, A., Rodriguez, D. J., Liu, W., Han, G. W., Joseph, J. S., Katritch, I., Heitman, L. H., Xia, L., IJzerman, A. P., et al. (2013) · Structure · doi:10.1016/j.str.2013.09.020 · Cited by 146
Self-citationWang, C. D., Gallaher, T., & Shih, J. C. (1993) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)13677-8 · Cited by 141
Hm1 muscarinic cholinergic receptor internalization requires a domain in the third cytoplasmic loop.
Lameh, J., Philip, M., Sharma, Y. K., Moro, O., Ramachandran, J., & Sadée, W. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42225-9 · Cited by 129
Costa, T., Lang, J., Gless, C., & Herz, A. (1990) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)10820-1 · Cited by 128
Ceresa, B. P., & Limbird, L. E. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)43916-6 · Cited by 126
Modeling the Adenosine Receptors: Comparison of the Binding Domains of A2AAgonists and Antagonists
Kim, S., Gao, Z., Rompaey, P. V., Gross, A. S., Chen, A., Calenbergh, S. V., & Jacobson, K. A. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm0300431 · Cited by 125
Ringholm, A., Kloviņš, J., Rudzish, R., Phillips, S. R., Rees, J. L., & Schiöth, H. B. (2004) · Journal of Investigative Dermatology · doi:10.1111/j.0022-202x.2004.23444.x · Cited by 124
Induced Effects of Sodium Ions on Dopaminergic G-Protein Coupled Receptors
Selent, J., Sanz, F., Pastor, M., & Fabritiis, G. D. (2010) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1000884 · Cited by 113
The Role of Water and Sodium Ions in the Activation of the μ‐Opioid Receptor
Yuan, S., Vogel, H., & Filipek, S. (2013) · Angewandte Chemie International Edition · doi:10.1002/anie.201302244 · Cited by 113
Allosteric modulation of A2A adenosine receptors by amiloride analogues and sodium ions
Gao, Z., & IJzerman, A. P. (2000) · Biochemical Pharmacology · doi:10.1016/s0006-2952(00)00360-9 · Cited by 106
Fanelli, F., Barbier, P., Zanchetta, D., Benedetti, P. G. D., & Chini, B. (1999) · Molecular Pharmacology · doi:10.1124/mol.56.1.214 · Cited by 105
Tao, Q., & Abood, M. E. (1998) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37469-5 · Cited by 102
Regulation of dopamine D2 receptors by sodium and pH.
Neve, K. A. (1991) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)11023-7 · Cited by 94
Nie, J., & Lewis, D. L. (2001) · Journal of Neuroscience · doi:10.1523/jneurosci.21-22-08758.2001 · Cited by 88
Gao, Z., Kim, S., Gross, A. S., Chen, A., Blaustein, J. B., & Jacobson, K. A. (2003) · Molecular Pharmacology · doi:10.1124/mol.63.5.1021 · Cited by 84
Flanagan, C. A., Zhou, W. J., Chi, L., Yuen, T., Rodic, V., Robertson, D. N., Johnson, M. S., Holland, P. J., Millar, R. P., Weinstein, H., et al. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.41.28880 · Cited by 83
Modeling and Mutational Analysis of a Putative Sodium-Binding Pocket on the Dopamine D2 Receptor
Neve, K. A., Cumbay, M. G., Thompson, K. R., Yang, R., Buck, D. C., Watts, V. J., DuRand, C. J., & Teeter, M. M. (2001) · Molecular Pharmacology · doi:10.1124/mol.60.2.373 · Cited by 79
Barbhaiya, H., McClain, R., IJzerman, A. P., et al. (1996) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09624-5 · Cited by 78
Selley, D. E., Cao, C., Liu, Q., & Childers, S. R. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703382 · Cited by 70
Voltage regulates adrenergic receptor function
Rinne, A., Birk, A., & Bünemann, M. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1212656110 · Cited by 61
Ardati, A., Henningsen, R. A., Higelin, J., et al. (1997) · Molecular Pharmacology · doi:10.1124/mol.51.5.816 · Cited by 61
Wilson, M. H., Highfield, H. A., & Limbird, L. E. (2001) · Molecular Pharmacology · doi:10.1124/mol.59.4.929 · Cited by 54
Biased Signaling of the Angiotensin II Type 1 Receptor Can Be Mediated through Distinct Mechanisms
Bonde, M. M., Hansen, J. T., Sanni, S. J., Haunsø, S., Gammeltoft, S., Lyngsø, C., & Hansen, J. L. (2010) · PLoS ONE · doi:10.1371/journal.pone.0014135 · Cited by 41
Hoare, S. R. J., Coldwell, M. C., Armstrong, D., & Strange, P. G. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703370 · Cited by 39
Seifert, R., & Wenzel‐Seifert, K. (2001) · PubMed · Cited by 39
Leppik, R. A., Mynett, A., Lazareno, S., & Birdsall, N. J. M. (2000) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)26407-5 · Cited by 38
Signaling mechanisms of GPCR ligands.
Strange, P. G. (2008) · PubMed · Cited by 37
Random Mutagenesis of the M3 Muscarinic Acetylcholine Receptor Expressed in Yeast
Li, B., Nowak, N. M., Kim, S., Jacobson, K. A., Bagheri, A., Schmidt, C. L., & Wess, J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m411623200 · Cited by 33
Heitman, L. H., Ye, K., Oosterom, J., & IJzerman, A. P. (2008) · Molecular Pharmacology · doi:10.1124/mol.107.043521 · Cited by 31
Voltage Affects the Dissociation Rate Constant of the m2 Muscarinic Receptor
Ben-Chaim, Y., Bochnik, S., Parnas, I., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0074354 · Cited by 28
Proulx, C. D., Holleran, B. J., Boucard, A. A., Escher, E., Guillemette, G., & Leduc, R. (2008) · Molecular Pharmacology · doi:10.1124/mol.108.045054 · Cited by 27
Mahmoud, S., Margas, W., Trapella, C., Calò, G., & Ruiz-Velasco, V. (2010) · Molecular Pharmacology · doi:10.1124/mol.109.062208 · Cited by 26
Cited by
Roth, B. L. (2016) · Neuron · doi:10.1016/j.neuron.2016.01.040 · Cited by 1,742
Self-citationVerkhratsky, A., & Nedergaard, M. (2018) · Physiological Reviews · doi:10.1152/physrev.00042.2016 · Cited by 1,678
GPCR Dynamics: Structures in Motion
Latorraca, N. R., Venkatakrishnan, A. J., & Dror, R. O. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.6b00177 · Cited by 835
Mechanisms of signalling and biased agonism in G protein-coupled receptors
Wootten, D., Christopoulos, A., Marti-Solano, M., Babu, M. M., & Sexton, P. M. (2018) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-018-0049-3 · Cited by 724
Singh, K. D., & Karnik, S. S. (2020) · GPCRs · doi:10.1016/b978-0-12-816228-6.00020-9 · Cited by 704
Metadata
- Authors
- Katritch, V., Fenalti, G., Abola, E. E., Roth, B. L., Cherezov, V., & Stevens, R. C.
- Venue
- Trends in Biochemical Sciences
- Publisher
- Elsevier BV
- Published
- 2014-05
- Volume
- 39
- Issue
- 5
- Pages
- 233-244
- ISSN
- 0968-0004 (ISSN-L)
- OpenAlex
- W2067973462
- Cited by
- 511
- References
- 88
- FWCI
- 2.98
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.